Compounds and their use in therapy
AssigneeSolvay Pharmaceuticals GmbH
InventorsLeena Hirvelae, Nina Johansson, Pasi Koskimies, Olli Pentikaeinen, Tommi Nyroenen, Tiina Salminen, Mark Johnson, Pekka Lehtovuori
Life of this patent
Estimating the term…
Abstract
Thiophenepyrimidinone compounds and their use in therapy, especially for use in the treatment and/or prevention of a steroid hormone dependent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring inhibition of 17β-hydroxysteroid dehydrogenase enzymes.
Claims41
A method of treating or inhibiting a steroid hormone dependent disease or disorder selected from the group consisting of breast cancer, prostate carcinoma, ovarian cancer, uterine cancer, endometrial cancer, endometrial hyperplasia, endometriosis, uterine fibroids, uterine leiomyoma, adenomyosis, dysmenorrhea, monorrhagia, metrorrhagia, prostadynia, benign prostatic hyperplasia, acne, seborrhoea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperplasia, polycystic ovarian syndrome and osteoporosis, said method comprising administering to a patient in need thereof an effective amount of a compound corresponding to formula (I)
- wherein
- X is S, SO or SO2
- R1 and R2 are individually selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloheteroalkyl, substituted cycloheteroalkyl, arylalkyl, substituted arylalkyl, heteroarylalkyl, substituted heteroarylalkyl, cycloheteroalkyl-alkyl, substituted cycloheteroalkyl-alkyl,
- whereby the cycloheteroalkyl moiety of cycloheteroalkyl-alkyl and substituted cycloheteroalkyl-alkyl is a four- to eight-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the number of N atoms being 0-3 and the number of O and S atoms each being 0-1, which ring may be saturated, partly unsaturated or hydroaromatic;
- whereby the cycloheteroalkyl moiety is optionally substituted by up to three substituents independently selected from the group consisting of oxo, alkyl, aryl or aryl-(C1-C4)-alkyl both optionally substituted in the aryl moiety, hydroxyl, (C1-C6)alkoxy, halogenated (C1-C6)alkyl, halogenated (C1-C6)alkoxy, carboxyl-(C1-C6)alkyl, thiol, nitrile, sulfamoyl, sulfonamide, carboxyl, aryloxy or arylalkyloxy both optionally substituted in the aryl moiety, (C1-C6)alkylthio, arylthio or arylalkylthio both optionally substituted in the aryl moiety, amino, amido, acyl, and acylamino;
- or R2 itself may be independently selected from acyl, carboxyl, or amido,
- wherein R1 and R2 cannot be simultaneously unsubstituted alkyl,
- the hydrocarbon chain —C(R3)-C(R4)-C(R5)-C(R6)- of the six-membered ring is saturated or contains one or two double bonds between the carbon atoms;
- R3 and R4 are individually selected from the group consisting of hydrogen, oxo, halogen or dihalogen, acyl, alkyl, substituted alkyl, hydroxyl, carboxyl, amido, amino, nitrile, thio, alkoxy, acyloxy, aryloxy, alkylthio and arylthio;
- R5 and R6 are individually selected from the group consisting of hydrogen, halogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, hydroxyl, alkoxy, aryloxy, or carboxyl,
- or a pharmaceutically acceptable salt thereof.
A compound corresponding to formula (I)
- wherein
- X is S, SO or SO2
- R1 and R2 are individually selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloheteroalkyl, substituted cycloheteroalkyl, arylalkyl, substituted arylalkyl, heteroarylalkyl, substituted heteroarylalkyl, cycloheteroalkyl-alkyl, and substituted cycloheteroalkyl-alkyl,
- whereby the cycloheteroalkyl moiety of cycloheteroalkyl-alkyl and substituted cycloheteroalkyl-alkyl is a four- to eight-membered heterocyclic ring containing at least one heteroatom selected from N, O and 5, the number of N atoms being 0-3 and the number of O and S atoms each being 0-1, which ring may be saturated, partly unsaturated or hydroaromatic;
- whereby the cycloheteroalkyl moiety is optionally substituted by up to three substituents independently selected from the group consisting of oxo, alkyl, aryl or aryl-(C1-C4)-alkyl both optionally substituted in the aryl moiety, hydroxyl, (C1-C6)alkoxy, halogenated (C1-C6)alkyl, halogenated (C1-C6)alkoxy, carboxyl-(C1-C6)alkyl, thiol, nitrile, sulfamoyl, sulfonamide, carboxyl, aryloxy or arylalkyloxy both optionally substituted in the aryl moiety, (C1-C6)alkylthio, arylthio or arylalkylthio both optionally substituted in the aryl moiety, amino, amido, acyl, and acylamino;
- or R2 itself may be independently selected from acyl, carboxyl, or amido,
- wherein R1 and R2 cannot be simultaneously unsubstituted alkyl, and
- wherein if R3, R5 and R6 all simultaneously represent hydrogen and R4 represents hydrogen or methyl, then R2 is different from methyl;
- R3 and R 4 are individually selected from the group consisting of hydrogen, oxo, halogen or dihalogen, acyl, alkyl, substituted alkyl, hydroxyl, carboxyl, amido, amino, nitrile, thio, alkoxy, acyloxy, aryloxy, alkylthio and arylthio;
- R5 and R6 are individually selected from the group consisting of hydrogen, halogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, hydroxyl, alkoxy, aryloxy, and carboxyl;
- the hydrocarbon chain —C(R3)-C(R4)-C(R5)-C(R6)- of the six-membered ring is saturated or contains one or two double bonds between the carbon atoms;
- and wherein if all the substituents R3, R4, R5 and R6 are simultaneously hydrogen, then the six-membered ring comprising the hydrocarbon chain —C(R3)-C(R4)-C(R5)-C(R6)- is an aromatic ring.
A compound corresponding to formula (I)
- wherein
- X is S, SO or SO2
- R1 and R2 are individually selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloheteroalkyl, substituted cycloheteroalkyl, arylalkyl, substituted arylalkyl, heteroarylalkyl, substituted heteroarylalkyl, cycloheteroalkyl-alkyl, substituted cycloheteroalkyl-alkyl,
- whereby the cycloheteroalkyl moiety of cycloheteroalkyl-alkyl and substituted cycloheteroalkyl-alkyl is a four- to eight-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the number of N atoms being 0-3 and the number of O and S atoms each being 0-1, which ring may be saturated, partly unsaturated or hydroaromatic;
- whereby the cycloheteroalkyl moiety is optionally substituted by up to three substituents independently selected from the group consisting of oxo, alkyl, aryl or aryl-(C1-C4)-alkyl both optionally substituted in the aryl moiety, hydroxyl, (C1-C6)alkoxy, halogenated (C1-C6)alkyl, halogenated (C1-C6)alkoxy, carboxyl (C1-C6)alkyl, thiol, nitrile, sulfamoyl, sulfonamide, carboxyl, aryloxy or arylalkyloxy both optionally substituted in the aryl moiety, (C1-C6)alkylthio, arylthio or arylalkylthio both optionally substituted in the aryl moiety, amino, amido, acyl, and acylamino;
- or R2 itself may be independently selected from acyl, carboxyl, or amido,
- wherein R1 and R2 cannot be simultaneously unsubstituted alkyl, and
- wherein if R3, R5 and R6 all simultaneously represent hydrogen and R4 represents hydrogen or methyl, then R2 is different from methyl;
- R3 and R 4 are individually selected from the group consisting of hydrogen, oxo, halogen or dihalogen, acyl, alkyl, substituted alkyl, hydroxyl, carboxyl, amido, amino, nitrile, thio, alkoxy, acyloxy, aryloxy, alkylthio and arylthio;
- R5 and R6 are individually selected from the group consisting of hydrogen, halogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, hydroxyl, alkoxy, aryloxy, or carboxyl,
- the hydrocarbon chain —C(R3)-C(R4)-C(R5)-C(R6)- of the six-membered ring is saturated or contains one or two double bonds between the carbon atoms;
- wherein if R3, R4, R5 and R6 are all simultaneously hydrogen, then the six membered ring comprising the hydrocarbon chain —C(R3)-C(R4)-C(R5)-C(R6)- is an aromatic ring;
- provided that said compound is not (3-Benzyl-7-tert-butyl-4-oxo-3,4,5,6,7,8-hexahydro-benzo[4,5]thieno[2,3-d]pyrimidin-2-yl)-acetic acid methyl ester or 2,3-Dibenzyl-7-tert-butyl-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d]pyrimidin-4-one.
Dependencies are inferred from the claim text.